ERBB2 and breast carcinoma: As expected, both the 5-membered ring (D5DO) and 7-membered ring (D7DO) showed no biological activity in EGFR- and HER2-overexpressing breast cancer cells since they deviate structurally from the pharmacophore by having a three- and a five-carbon linker, respectively [133].